Medtronic (MDT) Long-Term Deferred Tax (2014 - 2026)

Medtronic has disclosed Long-Term Deferred Tax across 13 years of filings, most recently posting $4.0 billion for Q1 2026.

• Long-Term Deferred Tax for Q1 2026 came in at $4.0 billion, up 9.77% year-over-year; the trailing twelve-month figure through Jan 2026 was $4.0 billion (up 9.77% YoY), and the FY2025 annual result was $4.0 billion, up 10.47% from the prior year.
• Long-Term Deferred Tax came in at $4.0 billion for Q1 2026 at Medtronic, up from $3.9 billion in the prior quarter.
• In the past five years, Long-Term Deferred Tax ranged from a high of $4.0 billion in Q2 2025 to a low of $3.3 billion in Q1 2022.
• The 5-year median for Long-Term Deferred Tax is $3.6 billion (2024), against an average of $3.6 billion.
• Across the five-year window, Long-Term Deferred Tax decreased 0.03% in 2022 and grew 10.55% in 2025, its largest moves.
• Medtronic's Long-Term Deferred Tax stood at $3.4 billion in 2022, then rose by 2.33% to $3.4 billion in 2023, then gained by 4.2% to $3.6 billion in 2024, then advanced by 7.98% to $3.9 billion in 2025, then increased by 2.85% to $4.0 billion in 2026.
• The last three Long-Term Deferred Tax figures came in at $4.0 billion (Q1 2026), $3.9 billion (Q4 2025), and $3.9 billion (Q3 2025), per Business Quant data.